Peptide Profiles
Evidence-weighted profiles for every peptide tracked by ClearBatch. Claims are rated by evidence tier, regulatory status is verified against primary sources (FDA, WADA, Health Canada), and each profile links to verified COA data for every vendor currently selling the peptide.
4 peptides trackedLast updated Apr 20, 2026
Evidence tier guide
Strong Human = RCTs, systematic reviews, regulatory approvalPreliminary Human = pilots, small trials, case seriesAnimal Only = rodent / preclinical onlyAnecdotal = podcasts, forums, no studiesUnsupported = marketing claim only
Tesamorelin
Strong HumanAn FDA-approved once-daily injectable GHRH(1-44) analog (Egrifta / Egrifta SV / Egrifta WR) approved only for reduction of excess abdominal fat in HIV-associated lipodystrophy — with extensive off-label use that is largely unsupported by independent human evidence.
7 human studies10 vendors
GHS / Metabolic
BPC-157
Preliminary HumanA synthetic 15-amino-acid peptide studied primarily in animal models for tissue healing, gut repair, and anti-inflammatory effects. Human data is very limited.
4 human studies21 vendors
Healing / Cytoprotective
Pinealon
Preliminary HumanA synthetic three-amino-acid peptide (Glu-Asp-Arg) developed by the Khavinson group in St. Petersburg and studied almost entirely in cell and animal models as a possible brain-protecting molecule, with very limited independent human data.
6 human studies5 vendors
Cognitive / Khavinson bioregulator
TB-500
Preliminary HumanA name that refers to either a synthetic 7-amino-acid peptide (Ac-LKKTETQ, the original veterinary product) or the full-length 43-residue thymosin beta-4; research peptide vendors typically sell the latter under the "TB-500" label despite the two being structurally distinct.
4 human studies12 vendors
Healing / Cytoprotective
Looking for vendor transparency instead? Browse the vendor directory.